Precision BioSciences, Inc. (DTIL) Ownership
DTIL ownership summary
as of October 18, 2026- Institutions
- 68.7% of shares outstanding
- Insiders
- 8.04% of shares outstanding
- Shares outstanding
- 27.6M
- Float
- 25.5M shares available to trade
- Short interest
- 9.33% 2.5M shares short
- Days to cover
- 9.96 short interest up 13.1% vs prior month
- Institutions 68.70%
- Insiders 8.04%
- Other investors 23.25%
DTIL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Aberdeen Group PLC | 8.08% | 2.2M | $12.9M | — | June 30, 2026 |
| 2 | Bleichroeder LP | 7.31% | 2.0M | $11.6M | +355,690 (+21.4%) | June 30, 2026 |
| 3 | Octagon Capital Advisors LP | 4.89% | 1.4M | $7.8M | −886,732 (−39.6%) | June 30, 2026 |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | 4.88% | 1.3M | $7.8M | +279,954 (+26.3%) | June 30, 2026 |
| 5 | BlackRock Inc | 4.25% | 1.2M | $6.8M | +973,112 (+487.1%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 4.04% | 1.1M | $6.4M | +205,501 (+22.6%) | June 30, 2026 |
| 7 | Lynx1 Capital Management, LP | 3.44% | 950K | $5.5M | −34,647 (−3.5%) | June 30, 2026 |
| 8 | Driehaus Capital Management LLC | 3.43% | 947K | $5.5M | −48,664 (−4.9%) | June 30, 2026 |
| 9 | Empery Asset Management, LP | 2.81% | 776K | $4.5M | −1.2M (−60.6%) | June 30, 2026 |
| 10 | Affinity Asset Advisors, LLC | 2.34% | 647K | $3.7M | +48,630 (+8.1%) | June 30, 2026 |
| 11 | Geode Capital Management, LLC | 2.25% | 621K | $3.6M | +333,891 (+116.3%) | June 30, 2026 |
| 12 | Mackenzie Investments | 1.74% | 481K | $2.8M | +480,997 (0.0%) | June 30, 2026 |
| 13 | State Street Corp | 1.55% | 427K | $2.5M | +354,383 (+485.8%) | June 30, 2026 |
| 14 | Acadian Asset Management LLC | 1.11% | 306K | $1.8M | +260,991 (+583.0%) | June 30, 2026 |
| 15 | ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 0.99% | 274K | $1.6M | +95,000 (+53.0%) | June 30, 2026 |
| 16 | CI Private Wealth LLC | 0.89% | 245K | $1.4M | +101,206 (+70.4%) | June 30, 2026 |
| 17 | Two Sigma Investments LLC | 0.86% | 238K | $1.4M | −69,927 (−22.7%) | June 30, 2026 |
| 18 | Northern Trust Corp | 0.69% | 190K | $1.1M | +114,119 (+150.0%) | June 30, 2026 |
| 19 | JPMorgan Chase & Co | 0.65% | 180K | $1.0M | +180,444 (+2,255,550.0%) | June 30, 2026 |
| 20 | Vanguard Fiduciary Trust Co | 0.60% | 167K | $960,924 | +10,912 (+7.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 3.8M shares and 5 cut 2.2M.
DTIL top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | abrdn World Healthcare | 4.15% | 1.1M | $6.6M | — | August 31, 2026 |
| 2 | abrdn Life Sciences Investors | 3.93% | 1.1M | $6.3M | — | August 31, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 2.82% | 778K | $4.5M | — | August 31, 2026 |
| 4 | iShares Russell 2000 ETF | 2.19% | 604K | $3.5M | −6,976 (−1.1%) | September 30, 2026 |
| 5 | Meridian Contrarian Legacy | 0.99% | 274K | $1.6M | +95,000 (+53.0%) | June 30, 2026 |
| 6 | Fidelity Small Cap Index | 0.95% | 262K | $1.5M | +1,674 (+0.6%) | July 31, 2026 |
| 7 | Canada Life US Small-Mid Cap Growth F | 0.91% | 251K | $1.4M | — | July 31, 2026 |
| 8 | iShares Russell 2000 Value ETF | 0.80% | 221K | $1.3M | +336 (+0.2%) | September 30, 2026 |
| 9 | Vanguard Russell 2000 ETF | 0.50% | 138K | $794,702 | +2,760 (+2.0%) | August 31, 2026 |
| 10 | Fidelity Extended Market Index | 0.47% | 130K | $748,029 | +3,557 (+2.8%) | August 31, 2026 |
| 11 | Fidelity Enhanced Small Cap Core ETF | 0.45% | 123K | $709,837 | +258 (+0.2%) | September 30, 2026 |
| 12 | iShares Micro-Cap ETF | 0.27% | 76K | $436,391 | −522 (−0.7%) | September 30, 2026 |
| 13 | Mackenzie GQE US Small Cap F8 | 0.23% | 62K | $359,165 | +28,468 (+84.3%) | July 31, 2026 |
| 14 | Schwab Small Cap Index | 0.21% | 58K | $336,547 | — | August 31, 2026 |
| 15 | Jacob Discovery Fd Instl | 0.19% | 52K | $300,554 | +5,000 (+10.6%) | June 30, 2026 |
| 16 | IG Mackenzie GQE U.S. Sm Md Cap Eq C NL | 0.19% | 51K | $294,726 | — | July 31, 2026 |
| 17 | Fidelity Total Market Index | 0.18% | 49K | $279,983 | — | August 31, 2026 |
| 18 | iShares Russell 2000 Small-Cap Idx Instl | 0.16% | 45K | $258,779 | — | August 31, 2026 |
| 19 | Fidelity Series Total Market Index | 0.15% | 40K | $231,741 | +3,098 (+8.4%) | August 31, 2026 |
| 20 | Goldman Sachs ActiveBeta® US SmCp Eq ETF | 0.13% | 37K | $210,813 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
DTIL insider transactions
latest 15| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | J. Jefferson Smith | Sell | $3.84 | 4,925 | $18,912 |
| 2026-02-18 | John Alexander Kelly | Sell | $3.84 | 8,149 | $31,292 |
| 2026-02-18 | Michael Amoroso | Sell | $3.84 | 20,559 | $78,947 |
| 2026-01-22 | Michael Amoroso | Sell | $4.17 | 34,799 | $145,112 |
| 2026-01-21 | J. Jefferson Smith | Sell | $4.03 | 10,200 | $41,106 |
| 2026-01-21 | John Alexander Kelly | Sell | $4.03 | 15,213 | $61,308 |
| 2025-12-16 | Geno J Germano | Buy | $4.72 | 3,000 | $14,160 |
| 2025-12-16 | Stanley Frankel | Buy | $4.70 | 2,700 | $12,690 |
| 2025-12-15 | Melinda Brown | Buy | $4.97 | 1,381 | $6,864 |
| 2025-11-03 | John Alexander Kelly | Sell | $6.49 | 1,303 | $8,456 |
| 2025-11-03 | Michael Amoroso | Sell | $6.49 | 3,409 | $22,124 |
| 2025-09-26 | Stanley Frankel | Buy | $4.97 | 2,700 | $13,419 |
| 2025-09-22 | Melinda Brown | Buy | $4.89 | 1,400 | $6,846 |
| 2025-07-03 | John Alexander Kelly | Sell | $4.26 | 14,827 | $63,163 |
| 2025-06-25 | Melinda Brown | Buy | $4.14 | 1,682 | $6,963 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
DTIL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns DTIL
Institutional investors own 68.7% of Precision BioSciences's shares and insiders 8.04%. The largest holder is Aberdeen Group PLC with 8.08% of the shares (2.2M), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 5 reduced their stake in the latest filings. Short interest is 9.33% of the float, or 9.96 days of average trading volume. The share count rose 1,817.2% since 2017.
Related: DTIL analyst forecast, DTIL key metrics. See the DTIL stock overview for the latest quote and news.
DTIL ownership FAQ
Who owns the most Precision BioSciences stock?
The largest shareholders of Precision BioSciences are Aberdeen Group PLC (8.08%), Bleichroeder LP (7.31%), Octagon Capital Advisors LP (4.89%), BOOTHBAY FUND MANAGEMENT, LLC (4.88%), BlackRock Inc (4.25%).
What percentage of Precision BioSciences is owned by institutions?
Institutions hold 68.7% of Precision BioSciences's shares outstanding; insiders hold 8.04%.
Which funds own Precision BioSciences?
The largest fund holders of Precision BioSciences are abrdn World Healthcare (4.15%), abrdn Life Sciences Investors (3.93%), Vanguard MStar Total Stk Mkt Idx Invest (2.82%), iShares Russell 2000 ETF (2.19%), Meridian Contrarian Legacy (0.99%).
What is Precision BioSciences's short interest?
2.5M shares of Precision BioSciences were sold short, 9.33% of the float; at the average daily volume it would take 9.96 days to cover.
Are insiders buying or selling Precision BioSciences?
Of the latest 15 reported insider transactions in Precision BioSciences (since June 25, 2025), 6 were purchases and 9 were sales.
How many shares of Precision BioSciences are outstanding?
Precision BioSciences has 27.6M shares outstanding, of which 25.5M are in the public float.